This research will create a new technique, capable of direct sequencing of single molecules of RNA, DNA and other oligonucleotides. By combining ultra sensitive quantum dots with scanning probe microscopy, molecular topology is recorded simultaneously with chemical composition at sub-nanometer resolution. This enables determination of the nucleoside sequence as well as the identification of single nucleotide polymorphisms, kinks, dislocations, and other mutations of the strand. The prototype and developed software will allow high throughput and automated sample analysis. This novel tool will be enabling for the realization of genetic-based healthcare (pharmacogenomics). By providing a direct, non-PCR method for genetic sequencing, routine application of this information to genetic predisposition screening, diagnosis, and prescription becomes available for clinical laboratories and hospitals. Expression and mutation studies can also be applied to drug development, as well as for more effective clinical trial candidate selection.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Small Business Innovation Research Grants (SBIR) - Phase I (R43)
Project #
1R43CA001790-01
Application #
6485447
Study Section
Special Emphasis Panel (ZRG1-SSS-Y (10))
Program Officer
Heath, Anne K
Project Start
2002-09-01
Project End
2004-08-31
Budget Start
2002-09-01
Budget End
2003-08-31
Support Year
1
Fiscal Year
2002
Total Cost
$203,352
Indirect Cost
Name
Quantum Logic Devices
Department
Type
DUNS #
City
Georgetown
State
TX
Country
United States
Zip Code
78626
Koul, Dimpy; Shen, Ruijun; Kim, Yong-Wan et al. (2010) Cellular and in vivo activity of a novel PI3K inhibitor, PX-866, against human glioblastoma. Neuro Oncol 12:559-69
Yee Koh, Mei; Spivak-Kroizman, Taly R; Powis, Garth (2008) HIF-1 regulation: not so easy come, easy go. Trends Biochem Sci 33:526-34